Conference Reports for NATAP
HIV Glasgow 2026
8-11 November
Back
 
Tweet
Antiviral Activity, Pharmacokinetics, and Safety of Oral GS-3242 for HIV-1 Treatment
Glasgow 2026 Nov 8-11
Glasgow:
Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV Glasgow
- (11/04/26)